Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Calithera Biosciences reported revenue of $0 for fiscal year 2022, down 100.0% from fiscal year 2021, and net income of -$21.29 million.
Figures from company filings; latest fiscal year ended December 31, 2022.
No profile data available.